Abstract
Anticancer therapy targets actively growing and dividing cells. Because of this characteristic, anticancer drugs assaults not only cancer cells but also normally proliferating cells such as blood cells, mucosal epithelial cells, and skin epithelial cells. Therefore, they inevitably have various side effects. Most of such side effects are mild and transient, but some can become severe and irreversible. To increase compliance with anticancer therapy and to maintain the quality of life of cancer patients, the complications of anticancer therapy must be well understood and properly managed.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Hesketh PJ (2008) Chemotherapy-induced nausea and vomiting. N Engl J Med 358:2482–2494
Daniel D, Crawford J (2006) Myelotoxicity from chemotherapy. Semin Oncol 33:74–85, Elsevier
Aapro M, Bohlius J, Cameron D et al (2012) 2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours. Eur J Cancer 47:8–32
Gibson RJ, Keefe DM (2006) Cancer chemotherapy-induced diarrhea and constipation: mechanisms of damage and prevention strategies. Support Care Cancer 14:890–900
Hartmann JT, Lipp HP (2003) Toxicity of platinum compounds. Expert Opin Pharmacother 4:889–901
Meisenberg B, Lassiter M, Hussein A et al (1994) Prevention of hemorrhagic cystitis after high-dose alkylating agent chemotherapy and autologous bone marrow support. Bone Marrow Transplant 14:287–291
Luce JK, Simons JA (1988) Efficacy of mesna in preventing further cyclophosphamide-lnduced hemorrhagic cystitis. Med Pediatr Oncol 16:372–374
Catane R, Schwade JG, Turrisi AT III et al (1979) Pulmonary toxicity after radiation and bleomycin: a review. Int J Radiat Oncol Biol Phys 5:1513–1518
Park S, Krishnan A, Lin C et al (2008) Mechanisms underlying chemotherapy-induced neurotoxicity and the potential for neuroprotective strategies. Curr Med Chem 15:3081–3094
Argyriou AA, Bruna J, Marmiroli P et al (2012) Chemotherapy-induced peripheral neurotoxicity (CIPN): an update. Crit Rev Oncol Hematol 82:51–77
Lee JJ, Swain SM (2006) Peripheral neuropathy induced by microtubule-stabilizing agents. J Clin Oncol 24:1633–1642
Bovelli D, Plataniotis G, Roila F (2010) Cardiotoxicity of chemotherapeutic agents and radiotherapy-related heart disease: ESMO Clinical Practice Guidelines. Ann Oncol 21:277–282
Shan K, Lincoff AM, Young JB (1996) Anthracycline-induced cardiotoxicity. Ann Intern Med 125:47–58
Keefe DM, Schubert MM, Elting LS et al (2007) Updated clinical practice guidelines for the prevention and treatment of mucositis. Cancer 109:820–831
Bruera E, Macmillan K, Kuehn N et al (1990) A controlled trial of megestrol acetate on appetite, caloric intake, nutritional status, and other symptoms in patients with advanced cancer. Cancer 66:1279–1282
Coiffier B, Altman A, Pui CH et al (2008) Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review. J Clin Oncol 26:2767–2778
Cortes J, Moore JO, Maziarz RT et al (2010) Control of plasma uric acid in adults at risk for tumor lysis syndrome: efficacy and safety of rasburicase alone and rasburicase followed by allopurinol compared with allopurinol alone-results of a multicenter phase III study. J Clin Oncol 28:4207–4213
Fidalgo JP, Fabregat LG, Cervantes A et al (2012) Management of chemotherapy extravasation: ESMO-EONS Clinical Practice Guidelines. Ann Oncol 23:167–173
Huang V, Anadkat M (2011) Dermatologic manifestations of cytotoxic therapy. Dermatol Ther 24:401–410
Janusch M, Fischer M, Marsch W et al (2006) The hand-foot syndrome-a frequent secondary manifestation in antineoplastic chemotherapy. Eur J Dermatol 16:494–499, 382
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Kim, KW., Roh, J.K., Wee, HJ., Kim, C. (2016). Complications of Anticancer Drugs and Their Management. In: Cancer Drug Discovery. Springer, Dordrecht. https://doi.org/10.1007/978-94-024-0844-7_10
Download citation
DOI: https://doi.org/10.1007/978-94-024-0844-7_10
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-024-0842-3
Online ISBN: 978-94-024-0844-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)